Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 2

Akiko Tozawa; Fuminori Kimura; Yasushi Takai; Takeshi Nakajima; Kimio Ushijima; Hiroaki Kobayashi; Toyomi Satoh; Miyuki Harada; Kohei Sugimoto; Shigehira Saji; Chikako Shimizu; Kyoko Akiyama; Hiroko Bando; Akira Kuwahara; Tatsuro Furui; Hiroshi Okada; Koji Kawai; Nobuo Shinohara; Koichi Nagao; Michio Kitajima; Souichi Suenobu; Toshinori Soejima; Mitsuru Miyachi; Yoko Miyoshi; Akihiro Yoneda; Akihito Horie; Yasushi Ishida; Noriko Usui; Yoshinobu Kanda; Nobuharu Fujii; Makoto Endo; Robert Nakayama; Manabu Hoshi; Tsukasa Yonemoto; Chikako Kiyotani; Natsuko Okita; Eishi Baba; Manabu Muto; Iwaho Kikuchi; Ken ichirou Morishige; Koichiro Tsugawa; Hiroyuki Nishiyama; Hajime Hosoi; Mitsune Tanimoto; Akira Kawai; Kazuhiko Sugiyama; Narikazu Boku; Masato Yonemura; Naoko Hayashi; Daisuke Aoki; Nao Suzuki; Yutaka Osuga

doi:10.1007/s10147-021-02076-7

Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 2

Akiko Tozawa, Fuminori Kimura, Yasushi Takai, Takeshi Nakajima, Kimio Ushijima, Hiroaki Kobayashi, Toyomi Satoh, Miyuki Harada, Kohei Sugimoto, Shigehira Saji, Chikako Shimizu, Kyoko Akiyama, Hiroko Bando, Akira Kuwahara, Tatsuro Furui, Hiroshi Okada, Koji Kawai, Nobuo Shinohara, Koichi Nagao, Michio KitajimaSouichi Suenobu, Toshinori Soejima, Mitsuru Miyachi, Yoko Miyoshi, Akihiro Yoneda, Akihito Horie, Yasushi Ishida, Noriko Usui, Yoshinobu Kanda, Nobuharu Fujii, Makoto Endo, Robert Nakayama, Manabu Hoshi, Tsukasa Yonemoto, Chikako Kiyotani, Natsuko Okita, Eishi Baba, Manabu Muto, Iwaho Kikuchi, Ken ichirou Morishige, Koichiro Tsugawa, Hiroyuki Nishiyama, Hajime Hosoi, Mitsune Tanimoto, Akira Kawai, Kazuhiko Sugiyama, Narikazu Boku, Masato Yonemura, Naoko Hayashi, Daisuke Aoki, Nao Suzuki, Yutaka Osuga

University Hospital

Research output: Contribution to journal › Article › peer-review

7 Citations (Scopus)

Abstract

The Japan Society of Clinical Oncology (JSCO) published the “JSCO Clinical Practice Guidelines 2017 for Fertility Preservation in Childhood, Adolescent, and Young Adult Cancer Patients” in 2017. This was the first guideline in cancer reproductive medicine in Japan. In the field of cancer reproductive medicine, close cooperation between an oncologist and a physician for reproductive medicine is important from before treatment initiation until long after treatment. The guideline takes into consideration disease specificity and provides opinions from the perspective of oncologists and specialists in reproductive medicine that are in line with the current state of the Japanese medical system. It is intended to serve as a reference for medical staff in both fields regarding the availability of fertility preservation therapy before the start of cancer treatment. Appropriate use of this guideline makes it easier to determine whether fertility preservation therapy is feasible and, ultimately, to improve survivorship in childhood, adolescent, and young adult cancer patients. In this article (Part 2), we describe details by organ/system and also for pediatric cancer.

Original language	English
Pages (from-to)	281-300
Number of pages	20
Journal	International Journal of Clinical Oncology
Volume	27
Issue number	2
DOIs	https://doi.org/10.1007/s10147-021-02076-7
Publication status	Published - Feb 2022

Keywords

Cancer
Childhood, adolescent and young adult (CAYA)
Fertility preservation
Practice guideline

ASJC Scopus subject areas

Surgery
Hematology
Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s10147-021-02076-7

Cite this

Tozawa, A., Kimura, F., Takai, Y., Nakajima, T., Ushijima, K., Kobayashi, H., Satoh, T., Harada, M., Sugimoto, K., Saji, S., Shimizu, C., Akiyama, K., Bando, H., Kuwahara, A., Furui, T., Okada, H., Kawai, K., Shinohara, N., Nagao, K., ... Osuga, Y. (2022). Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 2. International Journal of Clinical Oncology, 27(2), 281-300. https://doi.org/10.1007/s10147-021-02076-7

Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 2. / Tozawa, Akiko; Kimura, Fuminori; Takai, Yasushi et al.
In: International Journal of Clinical Oncology, Vol. 27, No. 2, 02.2022, p. 281-300.

Research output: Contribution to journal › Article › peer-review

Tozawa, A, Kimura, F, Takai, Y, Nakajima, T, Ushijima, K, Kobayashi, H, Satoh, T, Harada, M, Sugimoto, K, Saji, S, Shimizu, C, Akiyama, K, Bando, H, Kuwahara, A, Furui, T, Okada, H, Kawai, K, Shinohara, N, Nagao, K, Kitajima, M, Suenobu, S, Soejima, T, Miyachi, M, Miyoshi, Y, Yoneda, A, Horie, A, Ishida, Y, Usui, N, Kanda, Y, Fujii, N, Endo, M, Nakayama, R, Hoshi, M, Yonemoto, T, Kiyotani, C, Okita, N, Baba, E, Muto, M, Kikuchi, I, Morishige, KI, Tsugawa, K, Nishiyama, H, Hosoi, H, Tanimoto, M, Kawai, A, Sugiyama, K, Boku, N, Yonemura, M, Hayashi, N, Aoki, D, Suzuki, N & Osuga, Y 2022, 'Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 2', International Journal of Clinical Oncology, vol. 27, no. 2, pp. 281-300. https://doi.org/10.1007/s10147-021-02076-7

@article{1acd56172a4b4284bb209a07a79b5895,

title = "Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 2",

abstract = "The Japan Society of Clinical Oncology (JSCO) published the “JSCO Clinical Practice Guidelines 2017 for Fertility Preservation in Childhood, Adolescent, and Young Adult Cancer Patients” in 2017. This was the first guideline in cancer reproductive medicine in Japan. In the field of cancer reproductive medicine, close cooperation between an oncologist and a physician for reproductive medicine is important from before treatment initiation until long after treatment. The guideline takes into consideration disease specificity and provides opinions from the perspective of oncologists and specialists in reproductive medicine that are in line with the current state of the Japanese medical system. It is intended to serve as a reference for medical staff in both fields regarding the availability of fertility preservation therapy before the start of cancer treatment. Appropriate use of this guideline makes it easier to determine whether fertility preservation therapy is feasible and, ultimately, to improve survivorship in childhood, adolescent, and young adult cancer patients. In this article (Part 2), we describe details by organ/system and also for pediatric cancer.",

keywords = "Cancer, Childhood, adolescent and young adult (CAYA), Fertility preservation, Practice guideline",

author = "Akiko Tozawa and Fuminori Kimura and Yasushi Takai and Takeshi Nakajima and Kimio Ushijima and Hiroaki Kobayashi and Toyomi Satoh and Miyuki Harada and Kohei Sugimoto and Shigehira Saji and Chikako Shimizu and Kyoko Akiyama and Hiroko Bando and Akira Kuwahara and Tatsuro Furui and Hiroshi Okada and Koji Kawai and Nobuo Shinohara and Koichi Nagao and Michio Kitajima and Souichi Suenobu and Toshinori Soejima and Mitsuru Miyachi and Yoko Miyoshi and Akihiro Yoneda and Akihito Horie and Yasushi Ishida and Noriko Usui and Yoshinobu Kanda and Nobuharu Fujii and Makoto Endo and Robert Nakayama and Manabu Hoshi and Tsukasa Yonemoto and Chikako Kiyotani and Natsuko Okita and Eishi Baba and Manabu Muto and Iwaho Kikuchi and Morishige, {Ken ichirou} and Koichiro Tsugawa and Hiroyuki Nishiyama and Hajime Hosoi and Mitsune Tanimoto and Akira Kawai and Kazuhiko Sugiyama and Narikazu Boku and Masato Yonemura and Naoko Hayashi and Daisuke Aoki and Nao Suzuki and Yutaka Osuga",

note = "Funding Information: Members of the Guideline Review Committee behaved in accordance with the Japanese Society of Clinical Oncology (JSCO) Guidelines for Conflict of Interest Issues Related to Clinical Studies of Oncology. Potential conflicts of interest of individual committee members are declared at http://www.jsco-cpg.jp/item/32/coi.html . Development of these guidelines was funded by the JSCO. Neither the opinions nor the interests of the funding body (JSCO) affected the final guideline recommendations. Publisher Copyright: {\textcopyright} 2021, The Author(s) under exclusive licence to Japan Society of Clinical Oncology.",

year = "2022",

month = feb,

doi = "10.1007/s10147-021-02076-7",

language = "English",

volume = "27",

pages = "281--300",

journal = "International Journal of Clinical Oncology",

issn = "1341-9625",

publisher = "Springer Japan",

number = "2",

}

TY - JOUR

T1 - Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients

T2 - part 2

AU - Tozawa, Akiko

AU - Kimura, Fuminori

AU - Takai, Yasushi

AU - Nakajima, Takeshi

AU - Ushijima, Kimio

AU - Kobayashi, Hiroaki

AU - Satoh, Toyomi

AU - Harada, Miyuki

AU - Sugimoto, Kohei

AU - Saji, Shigehira

AU - Shimizu, Chikako

AU - Akiyama, Kyoko

AU - Bando, Hiroko

AU - Kuwahara, Akira

AU - Furui, Tatsuro

AU - Okada, Hiroshi

AU - Kawai, Koji

AU - Shinohara, Nobuo

AU - Nagao, Koichi

AU - Kitajima, Michio

AU - Suenobu, Souichi

AU - Soejima, Toshinori

AU - Miyachi, Mitsuru

AU - Miyoshi, Yoko

AU - Yoneda, Akihiro

AU - Horie, Akihito

AU - Ishida, Yasushi

AU - Usui, Noriko

AU - Kanda, Yoshinobu

AU - Fujii, Nobuharu

AU - Endo, Makoto

AU - Nakayama, Robert

AU - Hoshi, Manabu

AU - Yonemoto, Tsukasa

AU - Kiyotani, Chikako

AU - Okita, Natsuko

AU - Baba, Eishi

AU - Muto, Manabu

AU - Kikuchi, Iwaho

AU - Morishige, Ken ichirou

AU - Tsugawa, Koichiro

AU - Nishiyama, Hiroyuki

AU - Hosoi, Hajime

AU - Tanimoto, Mitsune

AU - Kawai, Akira

AU - Sugiyama, Kazuhiko

AU - Boku, Narikazu

AU - Yonemura, Masato

AU - Hayashi, Naoko

AU - Aoki, Daisuke

AU - Suzuki, Nao

AU - Osuga, Yutaka

N1 - Funding Information: Members of the Guideline Review Committee behaved in accordance with the Japanese Society of Clinical Oncology (JSCO) Guidelines for Conflict of Interest Issues Related to Clinical Studies of Oncology. Potential conflicts of interest of individual committee members are declared at http://www.jsco-cpg.jp/item/32/coi.html . Development of these guidelines was funded by the JSCO. Neither the opinions nor the interests of the funding body (JSCO) affected the final guideline recommendations. Publisher Copyright: © 2021, The Author(s) under exclusive licence to Japan Society of Clinical Oncology.

PY - 2022/2

Y1 - 2022/2

N2 - The Japan Society of Clinical Oncology (JSCO) published the “JSCO Clinical Practice Guidelines 2017 for Fertility Preservation in Childhood, Adolescent, and Young Adult Cancer Patients” in 2017. This was the first guideline in cancer reproductive medicine in Japan. In the field of cancer reproductive medicine, close cooperation between an oncologist and a physician for reproductive medicine is important from before treatment initiation until long after treatment. The guideline takes into consideration disease specificity and provides opinions from the perspective of oncologists and specialists in reproductive medicine that are in line with the current state of the Japanese medical system. It is intended to serve as a reference for medical staff in both fields regarding the availability of fertility preservation therapy before the start of cancer treatment. Appropriate use of this guideline makes it easier to determine whether fertility preservation therapy is feasible and, ultimately, to improve survivorship in childhood, adolescent, and young adult cancer patients. In this article (Part 2), we describe details by organ/system and also for pediatric cancer.

AB - The Japan Society of Clinical Oncology (JSCO) published the “JSCO Clinical Practice Guidelines 2017 for Fertility Preservation in Childhood, Adolescent, and Young Adult Cancer Patients” in 2017. This was the first guideline in cancer reproductive medicine in Japan. In the field of cancer reproductive medicine, close cooperation between an oncologist and a physician for reproductive medicine is important from before treatment initiation until long after treatment. The guideline takes into consideration disease specificity and provides opinions from the perspective of oncologists and specialists in reproductive medicine that are in line with the current state of the Japanese medical system. It is intended to serve as a reference for medical staff in both fields regarding the availability of fertility preservation therapy before the start of cancer treatment. Appropriate use of this guideline makes it easier to determine whether fertility preservation therapy is feasible and, ultimately, to improve survivorship in childhood, adolescent, and young adult cancer patients. In this article (Part 2), we describe details by organ/system and also for pediatric cancer.

KW - Cancer

KW - Childhood, adolescent and young adult (CAYA)

KW - Fertility preservation

KW - Practice guideline

UR - http://www.scopus.com/inward/record.url?scp=85122819675&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85122819675&partnerID=8YFLogxK

U2 - 10.1007/s10147-021-02076-7

DO - 10.1007/s10147-021-02076-7

M3 - Article

C2 - 35022887

AN - SCOPUS:85122819675

SN - 1341-9625

VL - 27

SP - 281

EP - 300

JO - International Journal of Clinical Oncology

JF - International Journal of Clinical Oncology

IS - 2

ER -

Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 2

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this